Quick Answer
Minerva Neurosciences, Inc. reported R&D Expense of $5.76 million for fiscal year 2025.
Minerva Neurosciences, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $5.76M | -51.6% |
| 2024 | $11.90M | -6.3% |
| 2023 | $12.71M | -13.3% |
| 2022 | $14.65M | -54.3% |
| 2021 | $32.04M | +45.4% |
| 2020 | $22.04M | -62.1% |
| 2019 | $58.12M | +66.6% |
| 2018 | $34.89M | +15.3% |
| 2017 | $30.26M | +48.0% |
| 2016 | $20.44M | +10.3% |
| 2015 | $18.53M | -56.8% |
| 2014 | $42.91M | +5956.3% |
| 2013 | $708.5K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $925.4K | -51.0% | -28.7% |
| June 30, 2025 | $1.30M | -66.4% | -4.7% |
| March 31, 2025 | $1.36M | -67.3% | -27.8% |
| September 30, 2024 | $1.89M | -45.2% | -51.1% |
| June 30, 2024 | $3.86M | +104.5% | -7.4% |
| March 31, 2024 | $4.17M | +57.0% | +21.0% |
| September 30, 2023 | $3.44M | +45.5% | +82.4% |
| June 30, 2023 | $1.89M | -54.3% | -28.9% |
- Minerva Neurosciences, Inc. showed a decrease of -51.6% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, Minerva Neurosciences, Inc.’s r&d expense has grown by 712.9% (from $708.5 thousand to $5.76 million).
- The most recent figure is from Minerva Neurosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: